# Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)

> **NCT00653341** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 764 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin glargine
- **DRUG:** NPH human insulin

## Key facts

- **NCT ID:** NCT00653341
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-01
- **Primary completion:** 2001-10
- **Final completion:** 2001-10
- **Target enrollment:** 764 (ACTUAL)
- **Last updated:** 2009-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00653341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00653341, "Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00653341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*